PMC:7408073 / 95445-95664 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T508","span":{"begin":162,"end":167},"obj":"Body_part"}],"attributes":[{"id":"A508","pred":"fma_id","subj":"T508","obj":"http://purl.org/sig/ont/fma/fma9670"}],"text":"Moreover, despite a significant increase of Ang II/Ang (1–7) ratio (that suggested a therapeutic use of recombinant hACE2 in PAH patients) systolic and diastolic blood pressures were in the range of normality [108,182]."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T191","span":{"begin":162,"end":167},"obj":"Body_part"}],"attributes":[{"id":"A191","pred":"uberon_id","subj":"T191","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Moreover, despite a significant increase of Ang II/Ang (1–7) ratio (that suggested a therapeutic use of recombinant hACE2 in PAH patients) systolic and diastolic blood pressures were in the range of normality [108,182]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3255","span":{"begin":51,"end":59},"obj":"Gene"},{"id":"3256","span":{"begin":116,"end":121},"obj":"Gene"},{"id":"3294","span":{"begin":129,"end":137},"obj":"Species"},{"id":"3296","span":{"begin":44,"end":50},"obj":"Gene"},{"id":"3327","span":{"begin":168,"end":177},"obj":"Disease"}],"attributes":[{"id":"A3255","pred":"tao:has_database_id","subj":"3255","obj":"Gene:284"},{"id":"A3256","pred":"tao:has_database_id","subj":"3256","obj":"Gene:59272"},{"id":"A3294","pred":"tao:has_database_id","subj":"3294","obj":"Tax:9606"},{"id":"A3296","pred":"tao:has_database_id","subj":"3296","obj":"Gene:24179"},{"id":"A3327","pred":"tao:has_database_id","subj":"3327","obj":"MESH:D006973"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Moreover, despite a significant increase of Ang II/Ang (1–7) ratio (that suggested a therapeutic use of recombinant hACE2 in PAH patients) systolic and diastolic blood pressures were in the range of normality [108,182]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T541","span":{"begin":125,"end":128},"obj":"Disease"}],"attributes":[{"id":"A541","pred":"mondo_id","subj":"T541","obj":"http://purl.obolibrary.org/obo/MONDO_0015924"}],"text":"Moreover, despite a significant increase of Ang II/Ang (1–7) ratio (that suggested a therapeutic use of recombinant hACE2 in PAH patients) systolic and diastolic blood pressures were in the range of normality [108,182]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1162","span":{"begin":18,"end":19},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T1163","span":{"begin":83,"end":84},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T1164","span":{"begin":162,"end":167},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T1165","span":{"begin":162,"end":167},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"}],"text":"Moreover, despite a significant increase of Ang II/Ang (1–7) ratio (that suggested a therapeutic use of recombinant hACE2 in PAH patients) systolic and diastolic blood pressures were in the range of normality [108,182]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T36261","span":{"begin":48,"end":50},"obj":"Chemical"},{"id":"T422","span":{"begin":125,"end":128},"obj":"Chemical"}],"attributes":[{"id":"A98914","pred":"chebi_id","subj":"T36261","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A5499","pred":"chebi_id","subj":"T422","obj":"http://purl.obolibrary.org/obo/CHEBI_104011"},{"id":"A60260","pred":"chebi_id","subj":"T422","obj":"http://purl.obolibrary.org/obo/CHEBI_31204"},{"id":"A75924","pred":"chebi_id","subj":"T422","obj":"http://purl.obolibrary.org/obo/CHEBI_33848"},{"id":"A29405","pred":"chebi_id","subj":"T422","obj":"http://purl.obolibrary.org/obo/CHEBI_53305"}],"text":"Moreover, despite a significant increase of Ang II/Ang (1–7) ratio (that suggested a therapeutic use of recombinant hACE2 in PAH patients) systolic and diastolic blood pressures were in the range of normality [108,182]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T461","span":{"begin":0,"end":219},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Moreover, despite a significant increase of Ang II/Ang (1–7) ratio (that suggested a therapeutic use of recombinant hACE2 in PAH patients) systolic and diastolic blood pressures were in the range of normality [108,182]."}

{"project":"2_test","denotations":[{"id":"32708755-29903860-20679019","span":{"begin":210,"end":213},"obj":"29903860"},{"id":"32708755-27432541-20679020","span":{"begin":214,"end":217},"obj":"27432541"}],"text":"Moreover, despite a significant increase of Ang II/Ang (1–7) ratio (that suggested a therapeutic use of recombinant hACE2 in PAH patients) systolic and diastolic blood pressures were in the range of normality [108,182]."}